These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2510086)

  • 1. Fructosamines in uraemia and renal replacement therapy.
    Beardsworth SF; Vernon V; Harrison D
    Nephrol Dial Transplant; 1989; 4(8):748-9. PubMed ID: 2510086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycated haemoglobin and fructosamine in non-diabetic subjects with chronic renal failure.
    Morgan LJ; Marenah CB; Morgan AG; Burden RP; John WG
    Nephrol Dial Transplant; 1990; 5(10):868-73. PubMed ID: 2128382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Value of plasma fructosamine in non-diabetic and diabetic chronic renal failure].
    Delattre J; Rottembourg J; Thuillier-Juteau Y; Allouache A; Villiamier C; Jaudon MC; Galli A
    Presse Med; 1989 Nov; 18(36):1781-4. PubMed ID: 2530565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical availability of serum fructosamine measurement in diabetic patients with uremia. Use as a glycemic index in uremic diabetes.
    Shoji T; Tabata T; Nishizawa Y; Kikunami K; Matsushita Y; Inoue T; Kenmotsu M; Miki T; Morii H
    Nephron; 1989; 51(3):338-43. PubMed ID: 2918945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycosylated and carbamylated haemoglobin in uraemia.
    Smith WG; Holden M; Benton M; Brown CB
    Nephrol Dial Transplant; 1989; 4(2):96-100. PubMed ID: 2496361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum glycated albumin and fructosamine in renal dialysis patients.
    Lamb E; Venton TR; Cattell WR; Dawnay A
    Nephron; 1993; 64(1):82-8. PubMed ID: 8502341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Determination of the metabolic condition in diabetics with renal insufficiency by means of the fructosamine test].
    Wagner R; Löwenstein I; Gieshoff B; Graben N; Olbricht T; Windeck R; Benker G; Reinwein D
    Dtsch Med Wochenschr; 1987 Jan; 112(5):175-7. PubMed ID: 3803236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The value of fructosamine in hemodialysis patients].
    Küenburg E; Brunnbauer M; Watzinger U; Winter F; Müller MM; Graf H; Prager R
    Wien Klin Wochenschr Suppl; 1990; 180():11-3; discussion 32-3. PubMed ID: 2321384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fructosamine levels in CAPD: its value as glycemic index.
    Coronel F; Macia M; Cidoncha A; Sanchez A; Tornero F; Barrientos A; Valor R
    Adv Perit Dial; 1991; 7():253-6. PubMed ID: 1680438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Determination of fructosamine in chronic kidney diseases (dialysis-dependent patients)].
    Peheim E; Descoeudres C; Diem P; Colombo JP; Vorberg E
    Wien Klin Wochenschr Suppl; 1990; 180():13-20; discussion 32-3. PubMed ID: 2321385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma 1,5-anhydroglucitol concentration in patients with end-stage renal disease with and without diabetes mellitus.
    Emoto M; Tabata T; Inoue T; Nishizawa Y; Morii H
    Nephron; 1992; 61(2):181-6. PubMed ID: 1630543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of serum globulins to total fructosamine in patients treated by haemodialysis.
    Hutchesson AC; Smith JM
    Ann Clin Biochem; 1995 Jul; 32 ( Pt 4)():419-21. PubMed ID: 7486804
    [No Abstract]   [Full Text] [Related]  

  • 13. Glycosylated haemoglobin in uraemia.
    Paisey R; Banks R; Holton R; Young K; Hopton M; White D; Hartog M
    Diabet Med; 1986; 3(5):445-8. PubMed ID: 2435450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of three methods to assess metabolic control in diabetic patients on CAPD treatment.
    Bilo HJ; Struijk DG; Boeschoten EW; Oe PL; Donker AJ
    Neth J Med; 1988 Dec; 33(5-6):217-24. PubMed ID: 3221941
    [No Abstract]   [Full Text] [Related]  

  • 15. Correction formula for carbamylated haemoglobin in diabetic uraemic patients.
    Hammouda AM; Mady GE
    Ann Clin Biochem; 2001 Mar; 38(Pt 2):115-9. PubMed ID: 11269750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactive glycosylation endproducts in diabetic uraemia and treatment of renal failure.
    Makita Z; Bucala R; Rayfield EJ; Friedman EA; Kaufman AM; Korbet SM; Barth RH; Winston JA; Fuh H; Manogue KR
    Lancet; 1994 Jun; 343(8912):1519-22. PubMed ID: 7911868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycated proteins as indices of glycaemic control in diabetic patients with chronic renal failure.
    Morgan L; Marenah CB; Jeffcoate WJ; Morgan AG
    Diabet Med; 1996 Jun; 13(6):514-9. PubMed ID: 8799653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Critical evaluation of fructosamine as a control parameter in the assessment of diabetic metabolic regulation].
    Hay U; Sedlmayer A; Müller MM; Dorda W; Schernthaner G
    Klin Wochenschr; 1989 Apr; 67(7):379-85. PubMed ID: 2747138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring.
    Vos FE; Schollum JB; Coulter CV; Manning PJ; Duffull SB; Walker RJ
    Nephrology (Carlton); 2012 Feb; 17(2):182-8. PubMed ID: 21883672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Glycosylated plasma proteins in chronic renal failure].
    Bordas-Fondrede M; Sauser E; Jardel C; Jaudon MC; Thervet F; Rottembourg J; Delattre J
    Ann Biol Clin (Paris); 1990; 48(10):717-21. PubMed ID: 2082760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.